Q3 2026 Earnings Season: Broad Beats Led by Eli Lilly, Caterpillar, Quanta Services
A wave of Q3 2026 earnings hit the tape with mostly strong beats: Eli Lilly crushed estimates with $24.4B in revenue (+39% YoY) driven by Mounjaro at $10.7B; Caterpillar delivered +45% EPS growth; Quanta Services posted a stunning +82% EPS beat and raised full-year guidance.
What we know
An account on X detailed Eli Lilly's blowout: $24.4B rev vs $22.61B est, Mounjaro at $10.7B (+65% YoY), FY guide raised to $91B–$92B from $85B–$87B. Another account on X highlighted Caterpillar's +17% revenue growth and 310bps operating margin expansion. Quanta Services was the biggest beat of the morning with revenue +57% and EPS +82%. Merck beat on Keytruda ($8.6B) and Gardasil ($2.0B). Hershey delivered EPS of $2.64, up 103% YoY. The one notable miss: D.R. Horton, where EPS fell 12% YoY and FY27 guidance came in well below estimates, signaling stress in the US homebuilding sector.
How the story developed
A wave of Q3 2026 earnings hit the tape with mostly strong beats: Eli Lilly crushed estimates with $24.4B in revenue (+39% YoY) driven by Mounjaro at $10.7B; Caterpillar delivered +45% EPS growth; Quanta Services posted a stunning +82% EPS beat and raised full-year guidance.
Major US economic releases hit at 8:30 AM EST today — PCE inflation, advance Q3 GDP, and initial jobless claims — alongside a heavy earnings slate including Caterpillar, Eli Lilly, and Carrier Global.
By the Global Eye 24 desk, with AI assistance. Updated as the story develops. Spot an error? Write to corrections@globaleye24.com.